Effect of saturated fatty acid-rich dietary vegetable oils on lipid profile, antioxidant enzymes and glucose tolerance in diabetic rats

被引:26
作者
Kochikuzhyil, Benson Mathai [1 ]
Devi, Kshama [1 ]
Fattepur, Santosh Raghunandan [1 ]
机构
[1] Al Ameen Coll Pharm, Dept Pharmacol, Bangalore, Karnataka, India
关键词
Antioxidant enzymes; atherogenicity; coconut oil; glucose tolerance; palm oil; saturated fatty acid; INSULIN-RESISTANCE; STRESSED RATS; SERUM-LIPIDS; LAURIC ACID; LIPOPROTEINS;
D O I
10.4103/0253-7613.66835
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To study the effect of saturated fatty acid (SFA)-rich dietary vegetable oils on the lipid profile, endogenous antioxidant enzymes and glucose tolerance in type 2 diabetic rats. Materials and Methods: Type 2 diabetes was induced by administering streptozotocin (90 mg/kg, i.p.) in neonatal rats. Twenty-eight-day-old normal (N) and diabetic (D) male Wistar rats were fed for 45 days with a fat-enriched special diet (10%) prepared with coconut oil (CO) - lauric acid-rich SFA, palm oil (PO) - palmitic acid-rich SFA and groundnut oil (GNO) - control (N and D). Lipid profile, endogenous antioxidant enzymes and oral glucose tolerance tests were monitored. Results: D rats fed with CO (D + CO) exhibited a significant decrease in the total cholesterol and non-high-density lipoprotein cholesterol. Besides, they also showed a trend toward improving antioxidant enzymes and glucose tolerance as compared to the D + GNO group, whereas D + PO treatment aggravated the dyslipidemic condition while causing a significant decrease in the superoxide dismutase levels when compared to N rats fed with GNO (N + GNO). D + PO treatment also impaired the glucose tolerance when compared to N + GNO and D + GNO. Conclusion: The type of FA in the dietary oil determines its deleterious or beneficial effects. Lauric acid present in CO may protect against diabetes-induced dyslipidemia.
引用
收藏
页码:142 / 145
页数:4
相关论文
共 23 条
  • [1] Aderibigbe AO, 1999, PHYTOTHER RES, V13, P504, DOI 10.1002/(SICI)1099-1573(199909)13:6<504::AID-PTR533>3.0.CO
  • [2] 2-9
  • [3] Benson MK, 2008, PHARMACOGN MAG, V4, P320
  • [4] Benson MK, 2009, INDIAN J EXP BIOL, V47, P98
  • [5] Dayrit C S., 2003, Philippine J Cardiol, V31, P97
  • [6] COMPARISON OF EFFECTS OF LAURIC ACID AND PALMITIC ACID ON PLASMA-LIPIDS AND LIPOPROTEINS
    DENKE, MA
    GRUNDY, SM
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 56 (05) : 895 - 898
  • [7] Edem DO, 2002, PLANT FOOD HUM NUTR, V57, P319, DOI 10.1023/A:1021828132707
  • [8] Enas E A, 1996, Indian Heart J, V48, P423
  • [9] FIFE B, DIABETES VIRGIN COCO
  • [10] INSULINOTROPIC POTENCY OF LAURIC ACID - A METABOLIC RATIONALE FOR MEDIUM CHAIN FATTY-ACIDS (MCF) IN TPN FORMULATION
    GARFINKEL, M
    LEE, S
    OPARA, EC
    AKWARI, OE
    [J]. JOURNAL OF SURGICAL RESEARCH, 1992, 52 (04) : 328 - 333